Global ADC Contract Manufacturing Market Report and Forecast 2024-2032

ADC Contract Manufacturing Market Overview

ADC contract manufacturing organizations (CMOs) manage intricate procedures like conjugation, drug payload synthesis, and antibody production, guaranteeing that ADCs are produced to exact specifications. By using external facilities and expertise for large-scale production, this service helps pharmaceutical companies cut costs and accelerate time-to-market. To meet both commercial and regulatory demands, companies without internal capabilities must use ADC contract manufacturing.

The market is primarily aided by the growing number of regulatory approvals for ADCs granted by agencies such as the FDA and EMA. Simplified approval procedures for ADCs promote more development because of their potential to fill medical needs that aren't being met. Businesses are investing in ADCs with greater assurance as regulations become more favourable and clearer. Hence, driving the business opportunity for ADC contract manufacturing.

ADC Contract Manufacturing Market Growth Drivers

Rising Investments in Biotechnology to Drive Market Growth

The market growth is accelerated by increased funding for biotechnology and ADC-related research from the public and private sectors. Innovation in biopharmaceutics encourages the creation of new ADC products and production capacities. This capital inflow helps established businesses as well as startups grow their ADC pipelines, thereby, bolstering the market's growth during the forecast period.

ADC Contract Manufacturing Market Trends

ADC Contract Manufacturing Market Segmentation

ADC Contract Manufacturing Market Share

The Cleavable Segment Holds a Significant Market Share

The market segmentation by linker is divided into cleavable linker and non-cleavable linker. Precise delivery is ensured by cleavable linkers in ADCs, which are chemical bonds that release the drug payload inside target cancer cells. These intricate linkers, which need to be produced with extreme precision for efficient drug release, are the specialty of ADC contract manufacturers. Consequently, cleavable linkers are expected to lead the market share in the forecast period.

ADC Contract Manufacturing Market Analysis by Region

Regionally, North America is expected to dominate the market during the forecast period. This can primarily be ascribed to the rise in the prevalence of cancer and autoimmune diseases along with the growth in the geriatric population in the region. The United States dominated the market in North America in 2021 owing to factors such as a high patient pool for major chronic diseases. Additionally, over the forecast period, the presence of major players, early adoption of technologically advanced products, and an increase in research and development activities are expected to propel regional growth in the market.

Leading Players in the Global ADC Contract Manufacturing Market

The key features of the market report comprise the patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading key players. The major companies in the market are as follows:

Samsung Biologics

Founded in 2011, Samsung Biologics is a top contract development and manufacturing organization (CDMO) with a focus on biopharmaceuticals, with its headquarters located in Incheon, South Korea. The company uses cutting-edge facilities and biologics knowledge to provide a wide range of services, including ADC contract manufacturing. It provides end-to-end solutions from development to commercial-scale production, which benefits multinational pharmaceutical companies.

Lonza

It is a global leader in contract manufacturing and development services, with a focus on biologics, including...

*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*

Other key players in the market include Catalent, Inc., Siegfried Holding AG, Piramal Pharma Limited, Sartorius AG, WuXi Biologics, and Sterling Pharma Solutions Limited (PMDO) among others.

Key Questions Answered in the ADC Contract Manufacturing Market Report

• What was the global ADC contract manufacturing market value in 2023?
• What is the global ADC contract manufacturing market forecast outlook for 2024-2032?
• What are the regional markets covered in the EMR report?
• What is market segmentation based on linker?
• What is the market breakup based on application?
• What are the major factors aiding the global ADC contract manufacturing market demand?
• How has the market performed so far and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• Which regional market is expected to lead the market share in the forecast period?
• Which country is expected to experience expedited growth during the forecast period?
• How does the prevalence and incidence of chronic diseases affect the market landscape?
• What are the major global ADC contract manufacturing market trends?
• How does the rise in the geriatric population impact the market size?
• Which product type will dominate the market share?
• Which application is expected to have a high market value in the coming years?
• Which end user is projected to contribute to the highest market growth?
• Who are the key players involved in the ADC contract manufacturing market?
• What is the patent landscape of the market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?